New study aims to cut asthma inhaler carbon emissions with smart prescribing tool

NCT ID NCT07638735

First seen Jun 16, 2026

Summary

This study tests a computer tool called eAMS-Eco that helps doctors choose asthma inhalers with a lower carbon footprint. The tool adds environmental information to existing asthma treatment recommendations. Researchers will see if using this tool in four clinics reduces inhaler-related carbon emissions and costs, while keeping asthma control stable. About 95 patients and their doctors are taking part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sinai Health Family Health Team (Toronto Site)

    Toronto, Ontario, M5T 3L9, Canada

  • Sinai Health Family Health Team (Vaughan Site)

    Vaughan, Ontario, L6A 3Z8, Canada

  • Taddle Creek Family Health Team (Bay Street)

    Toronto, Ontario, M5G 1N8, Canada

  • Taddle Creek Family Health Team (Bloor Street)

    Toronto, Ontario, M6G 4A1, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Climate-Conscious Clinical Decision Support System for Asthma Management (eAMS-Eco)

What this could lead to

If successful, this tool could help doctors prescribe inhalers that are better for the environment while maintaining good asthma control, potentially reducing healthcare's carbon footprint.

What could go wrong

This is a small, early-stage study with only 95 participants across four clinics. It focuses on prescribing behavior, not direct health outcomes, so the impact on patient health or the environment may be limited or not generalizable.

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.